Vesalius receives authorization from Health Canada to conduct investigational testing. The Investigational Testing Authorization is for 5 patients at St. Paul’s Hospital in Vancouver. This authorization was followed by the approval of the Research Ethics Board of the hospital.
The authorization and the approval allow Vesalius to initiate the First-In-Human study. You can find here more details about the FIH ITA Study – Vesalius TMVr System for Symptomatic Degenerative Mitral Regurgitation, currently recruiting patients.